Expertise in
3
conditions

Emmanuel A. Laffitte

Geneve, GE, CH 
Expertise in
3
conditions
Geneve, GE, CH 

Overview

Emmanuel Laffitte practices practicing medicine in Geneve, Switzerland.

Mr. Laffitte is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Pityriasis Rubra Pilaris, Follicular Ichthyosis, Discoid Lupus Erythematosus (DLE), and Localized Scleroderma.

He is actively involved in clinical research, co-authoring 73 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Geneve, GE, Switzerland
Other Locations
Lausanne, VD, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Multicenter, Double-Blind Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Adult Patients With Atopic Dermatitis
A Phase 3 Multicenter, Double-Blind Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Adult Patients With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 03, 2024
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Safety and Efficacy of Baricitinib in Combination With Topical Corticosteroids in Adult Patients With Moderate-to-Severe Atopic Dermatitis Who Have Experienced Failure to Cyclosporine or Are Intolerant to, or Have Contraindication to, Cyclosporine
A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Safety and Efficacy of Baricitinib in Combination With Topical Corticosteroids in Adult Patients With Moderate-to-Severe Atopic Dermatitis Who Have Experienced Failure to Cyclosporine or Are Intolerant to, or Have Contraindication to, Cyclosporine
Enrollment Status: Completed
Publish Date: May 14, 2024
Intervention Type: Drug
Study Drugs: Baricitinib, Corticosteroid
Study Phase: Phase 3
View 1 Less Clinical Trial

73 Total Publications

Finger Allergic Contact Dermatitis by Proxy Induced by Feline Thiamazole Cream.
Finger Allergic Contact Dermatitis by Proxy Induced by Feline Thiamazole Cream.
Journal: Contact dermatitis
Published: June 08, 2026

Frequently Asked Questions about Emmanuel A. Laffitte

Is Emmanuel A. Laffitte a top-rated expert for Pityriasis Rubra Pilaris?

MediFind is an objective health platform that identifies experts based on real-world data. Emmanuel A. Laffitte is classified as an Distinguished expert for Pityriasis Rubra Pilaris, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Emmanuel A. Laffitte participate in research or clinical trials?

Yes. Emmanuel A. Laffitte has published 73 articles and abstracts on conditions like Pityriasis Rubra Pilaris. You can view a list of Emmanuel A. Laffitte's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Laffitte's expertise for a condition
ConditionClose
    View All 33 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile